1-3 of 3
Luba Platt
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Aspirin Decreases the Thrombotic Complications (DVT) of Liposomal Doxorubicin, Vincristine, Decreased Frequency Dexamethasone and Thalidomide (DVd-T) Treatment of Multiple Myeloma (MM).

Rachid Baz, M.D., Kandice Marchant, M.D., Erin O. Yiannaki, M.S., Luba Platt, Catherine Brand, Elisa Tso, M.D., Mohamad A. Hussein, M.D.
Journal: Blood
Blood (2004) 104 (11): 2397.
https://doi.org/10.1182/blood.V104.11.2397.2397
Published: 2004
Journal Articles

A Phase II Trial of Doxil, Vincristine and Reduced Schedule Dexamethasone (DVd) for Patients with Relapsed or Refractory Multiple Myeloma.

Paul Masci, D.O., Mary A. Karam, R.N., Luba Platt, B.S., Steven Andresen, D.O, Alan Lichtin, M.D., Bridget McGowan, B.S., Mohamad Hussein, M.D.
Journal: Blood
Blood (2004) 104 (11): 2415.
https://doi.org/10.1182/blood.V104.11.2415.2415
Published: 2004
Journal Articles

Arsenic Trioxide (Trisenox® ATO), Ascorbic Acid (AA) and Dexamethasone (Dex) Pulses (TAD) for Relapsed Refractory Progressive Multiple Myeloma (MM) Patients (pts); a Final Report.

Rony M. Abou-Jawde, MD, Janice Reed, RN, Megan Kelly, Luba Platt, BS, Mary Ann Karam, RN, Mary Ruth Kovak, MSN, MBA, Gordan Srkalovic, MD, PhD, Mohamad A. Hussein, MD
Journal: Blood
Blood (2004) 104 (11): 2419.
https://doi.org/10.1182/blood.V104.11.2419.2419
Published: 2004